| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/25/2002 | CN1370525A Application of glycine in preparing medicine |
| 09/25/2002 | CN1370524A Lovamin and its prepn process |
| 09/25/2002 | CN1370520A Spot eliminating ointment |
| 09/25/2002 | CN1370468A Theanine product |
| 09/25/2002 | CN1370429A Health food |
| 09/25/2002 | CN1091446C Colchicine derivatives, use thereof and formulations containing them |
| 09/25/2002 | CN1091443C New imidazoline compounds, process for preparing them and pharmaceutical composition containing them |
| 09/25/2002 | CN1091441C Amlo dipine mesylate and its preparation and application |
| 09/25/2002 | CN1091438C 0-acyl-4-phenyl-cyclohexanols, their salts, medicaments containing such compounds and their use, as well as method of preparing them |
| 09/25/2002 | CN1091382C Compound lingxian headache treating medicine and its preparation |
| 09/25/2002 | CN1091379C Detoxicating instant particles and preparing method thereof |
| 09/25/2002 | CN1091375C Nucleic acid hypoglycemic mixture |
| 09/25/2002 | CN1091374C External medicine for treating sore caused by shell wound or bullet wound |
| 09/25/2002 | CN1091372C Medicine for curing brain dysfunction and epilepsy |
| 09/25/2002 | CN1091371C Skin nursing cream for curing comedo |
| 09/25/2002 | CN1091370C Usage of schube thinamine in preparation of medicinal composition for treating mental motional and psychological intelligent diseases |
| 09/25/2002 | CN1091369C Ointment for treating face mite disease |
| 09/25/2002 | CN1091368C Pharmaceutical composition comprising coenzyme Q10 |
| 09/25/2002 | CN1091363C 脂肪掺合物 Fat blend |
| 09/24/2002 | WO2001072289A2 Medicament for the stimulation of leucopoiesis and treatment of tumour and protozoan diseases acarinosis and arthropod-borne diseases and a method for production thereof |
| 09/24/2002 | US6455734 Antagonists of the magnesium binding defect as therapeutic agents and methods for treatment of abnormal physiological states |
| 09/24/2002 | US6455709 Such as 1,3-dimethyl-fulleropyrrolidine-1,3-dicarboxylic n-amide oligomer |
| 09/24/2002 | US6455703 1,3,6,-Trihydro-6-aza-3-oxapentalen-2-one derivatives for the treatment of neoplasia |
| 09/24/2002 | US6455700 Process for preparing guanidine and amidine derivatives |
| 09/24/2002 | US6455699 Camptothecin analogs and methods of preparation thereof |
| 09/24/2002 | US6455690 L-8-oxo-7-propyl-7,8-dihydro-(9H)-guanosine |
| 09/24/2002 | US6455689 Antisense-oligonucleotides for transforming growth factor-β (TGF-β) |
| 09/24/2002 | US6455686 Dermatophagoides nucleic acid molecules, proteins and uses thereof |
| 09/24/2002 | US6455680 Methods utilizing aryl thioimines in synthesis of erythromycin derivatives |
| 09/24/2002 | US6455674 Polypeptide for use in the diagnosis and treatment of tissue oxygenation defects |
| 09/24/2002 | US6455671 Thrombin inhibitors, the preparation and use thereof |
| 09/24/2002 | US6455592 Use of hydrophilic penetration agents in dermatological compositions for the treatment of onychomycoses, and corresponding compositions |
| 09/24/2002 | US6455591 Diethylhomospermine or other polyamine derivatives and salts as anti-secretory, nitric oxide agonist, nitric oxide synthase activating or gastrointestinal anti-spasmodic agents |
| 09/24/2002 | US6455590 Administering a therapeutically effective amount of a deprenyl compound to a glaucoma patient |
| 09/24/2002 | US6455589 Primary N-hydroxylamines |
| 09/24/2002 | US6455588 Compositions including modafinil for treatment of eating disorders and for appetite stimulation |
| 09/24/2002 | US6455586 Human contact sensitizers; vehicles consisting of non-volatile, nonionic surfactants and esters of isopropyl alcohol and myristic acid and palmitic acid |
| 09/24/2002 | US6455585 Have a higher analgesic activity, a lower toxicity and a longer effective time period than tramadol. |
| 09/24/2002 | US6455584 Growth inhibition of vascular smooth muscle; prevention or therapy of the restenosis after ptca. |
| 09/24/2002 | US6455583 Method for treating meibomian gland disease |
| 09/24/2002 | US6455582 Treating cancer |
| 09/24/2002 | US6455581 Inhibitors of hiv protease. |
| 09/24/2002 | US6455580 Method and composition for antiviral therapy |
| 09/24/2002 | US6455578 Aromatic derivatives and iron complexes thereof for the use as normalizing agents of the iron level |
| 09/24/2002 | US6455576 Macrolides with anti-inflammatory activity |
| 09/24/2002 | US6455574 Administering a combinations of amlodipine or a pharmaceutically acceptable acid addition salt thereof and atorvastatin or a pharmaceutically acceptable salt thereof for treatment of combined hypertension and hyperlipidemia |
| 09/24/2002 | US6455573 Synthesizing salacinol, its stereoisomers, and non-naturally occurring selenium and nitrogen analogues thereof |
| 09/24/2002 | US6455572 Estrogen agonist/antagonist metabolites |
| 09/24/2002 | US6455571 Inhibitors of neuraminidases |
| 09/24/2002 | US6455569 Connective tissue softening |
| 09/24/2002 | US6455567 Treating dermatological disorders by administering a 3-(pyrrolidin-2-ylmethyl)-5-(aminosulfonylmethyl)indole |
| 09/24/2002 | US6455566 Substituted 1-aryl-3-heteroaryl-thioureas (or isothioureas) as antiatherosclerotic agents |
| 09/24/2002 | US6455565 Method for inhibiting skin lesion formation using histamine as the active ingredient |
| 09/24/2002 | US6455564 Oral administration of (5r)-(methylamino)-5,6-dihydro-4h-imidazo(4,5,1-ij)quinolin-2( '1h)-one or -thione |
| 09/24/2002 | US6455562 Cyclic AMP-specific phosphodiesterase inhibitors |
| 09/24/2002 | US6455561 Administering benzofuran derivative for therapy of disease state that is capable of being modulated by inhibition of phosphodiesterase iv or tumour necrosis factor |
| 09/24/2002 | US6455557 Method of reducing somnolence in patients treated with tizanidine |
| 09/24/2002 | US6455555 Photosensitizing dye that is a quinolinium- or thiazolium-methine dye |
| 09/24/2002 | US6455553 Method for treating a demyelinating condition |
| 09/24/2002 | US6455552 Combination of a GABAA α5 inverse agonist and a muscarinic agonist |
| 09/24/2002 | US6455551 Use of 1-hydroxy-2-pyridones for treating mucosa diseases which are difficult to treat |
| 09/24/2002 | US6455548 4-alkyl piperidinyl pyrrolidine modulators of chemokine receptor activity |
| 09/24/2002 | US6455547 Method for treating pharmaceutical compositions |
| 09/24/2002 | US6455546 By administering to a female mammal such as mare or cow a dopamine d2 receptor antagonist such as domperidone |
| 09/24/2002 | US6455545 Gastrointestinal disorders |
| 09/24/2002 | US6455544 Use of cholinesterase inhibitors to treat disorders of attention |
| 09/24/2002 | US6455543 Cis-2,6-disubstituted piperidines for the treatment of psychostimulant abuse and withdrawal, eating disorders, and central nervous system diseases and pathologies |
| 09/24/2002 | US6455542 Piperidine and pyrrolidine derivatives comprising a nitric oxide donor for treating stress |
| 09/24/2002 | US6455541 Suppression, by 5-lipoxygenase inhibitors, of bone resorption |
| 09/24/2002 | US6455540 Methods of use of quinolone compounds against anaerobic pathogenic bacteria |
| 09/24/2002 | US6455538 1,2,3,4,5,6-Hexahydro-2,6-methano-3-benzazocin-10-ols |
| 09/24/2002 | US6455537 Methods for treating opiate intolerance |
| 09/24/2002 | US6455536 Treatment of dyskinesia |
| 09/24/2002 | US6455534 Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family |
| 09/24/2002 | US6455533 Substituted benzhydrylpiperazines such as cetirizine, hydroxyzine, efletirizine, meclizine and buclizine, the optically active isomers thereof and the pharmaceutically acceptable salts thereof. |
| 09/24/2002 | US6455532 Pyrazinone thrombin inhibitors |
| 09/24/2002 | US6455530 2R,4S,S,S- and 2S,4R,S,S-hydroxyitraconazole |
| 09/24/2002 | US6455529 Adhesion receptor antagonists |
| 09/24/2002 | US6455528 Tumor necrosis factor antagonist and/or interleukin promoter; antiallergens, antiinflammatory agents; autoimmune disease treatment |
| 09/24/2002 | US6455527 High affinity ligands for nociceptin receptor ORL-1 |
| 09/24/2002 | US6455526 Biodegradable polymer encapsulated pharmaceutical compositions and method for preparing the same |
| 09/24/2002 | US6455525 Heterocyclic substituted pyrazolones |
| 09/24/2002 | US6455524 Medicament compositions based on anticholinergically-effective compounds and beta-mimetics |
| 09/24/2002 | US6455523 Inhibitors of farnesyl protein transferase |
| 09/24/2002 | US6455522 Cyclic sulfonamide derivatives as metalloproteinase inhibitors |
| 09/24/2002 | US6455521 Psychological disorders; side effect reduction |
| 09/24/2002 | US6455520 Benzamide derivatives and their use as cytokine inhibitors |
| 09/24/2002 | US6455518 Pharmaceutical compositions for the treatment of transplant rejection, autoimmune or inflammatory conditions comprising cyclosporin a and 40-O-(2-hydroxyethyl)-rapamycin |
| 09/24/2002 | US6455517 For therapy of conditions or diseases that are estrogen-dependent, i.e., are estrogen-induced or estrogen-stimulated |
| 09/24/2002 | US6455516 Administering epiallopregnanolone as antidepressant, cognition activator, or antiepileptic agent; treatment of premenstrual syndrome |
| 09/24/2002 | US6455514 Process for treating lameness by administration of a bisphosphonic acid derivative |
| 09/24/2002 | US6455513 Chemical compounds |
| 09/24/2002 | US6455510 Chemical Compounds |
| 09/24/2002 | US6455508 Methods for treating diseases with tirazole and pyrrolo-pyrimidine ribofuranosyl nucleosides |
| 09/24/2002 | US6455507 Benzimidazole derivatives |
| 09/24/2002 | US6455506 Lyxofuranosyl benzimidazoles as antiviral agents |
| 09/24/2002 | US6455505 Derivatives . . . use as medicaments |
| 09/24/2002 | US6455504 Pesticidal macrolides |
| 09/24/2002 | US6455502 Compounds and compositions as protease inhibitors |
| 09/24/2002 | US6455497 Methods and materials for treating inflammatory diseases |